Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Second dose of measles vaccine at 18 months
NCT02943681Completed
- Sponsor
- Bandim Health Project
- Start
- Oct 2016
- Primary completion
- May 2020
- Modality
- Live Attenuated Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
Randomised, open-label trial of measles virus vaccine live in measles (2 arms), sponsored by Bandim Health Project. Primary endpoints: Mortality at 30 months and Hospital admissions at 30 months. Started Oct 2016; status: completed.
02
Drugs
measles virus vaccine live
03
Conditions
measles
Beyond the preview
Go deeper on NCT02943681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02943681.